Hecht, M., Blümle, A., Binder, H., Schumacher, M., & Binder, N. [ca. 2025]. Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT) [Cd]. Freiburg: Universität. https://doi.org/10.1186/s12874-025-02535-z
ISO-690 (author-date, English)HECHT, Manuel, BLÜMLE, Anette, BINDER, Harald, SCHUMACHER, Martin und BINDER, Nadine, 2025. Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT). Freiburg: Universität.
Modern Language Association 9th editionHecht, M., A. Blümle, H. Binder, M. Schumacher, und N. Binder. Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT). cd, Universität, 2025, https://doi.org/10.1186/s12874-025-02535-z.
Mohr Siebeck - Recht (Deutsch - Österreich)Hecht, Manuel/Blümle, Anette/Binder, Harald/Schumacher, Martin/Binder, Nadine: Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT), Freiburg 2025.
Emerald - HarvardHecht, M., Blümle, A., Binder, H., Schumacher, M. und Binder, N. (2025), Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT), Bd. , Universität, Freiburg, verfügbar unter:https://doi.org/10.1186/s12874-025-02535-z.